Our Board of Advisors

John leads the Office of Zone Learning overseeing the institutional strategy and direction of the 10 innovation zones at Toronto Metropolitan University.

Previously, John led institutional initiatives at the Office of the Vice-President, Research & Innovation (OVPRI) including management of the Canadian Accelerator and Incubator Program and the Ontario Campus-Linked Accelerator (CLA) funding to the zones. John is also a founding director of I-INC, the national network connecting university-based innovation hubs across Canada.  

John was Regional Director for a provincial innovation funding agency and in the private sector, spent over 15 years in international business development for large industrial control systems projects in China, United States, Brazil, Taiwan and Canada.

Sebastien joined Dynacare in 2020 as Vice-President, Government Relations. Prior to joining Dynacare, Sebastien developed a recognized expertise in government affairs, health policy and market access through opportunities with Fortune 500 organizations including Merck, Sanofi Genzyme, Bristol-Myers Squibb and Baxter International Inc.

He holds a baccalaureate degree in Science (B.Sc.) from the Université du Québec à Montréal, an Executive Master of Business Administration (MBA) from the University of Paris-Dauphine and a Master of Laws (LL.M.) with a specialization in Innovation and technology from the University of Toronto Faculty of Law.

Tim Dutton is the Director of Corporate Affairs at Intellijoint Surgical, a leading Canadian medtech business that develops technologies to improve patient outcomes in joint replacement surgery.

In this role, he is responsible for strategy, stakeholder relations, and public policy and leads projects that drive long-term growth for the business. Prior to this, Tim was the Director of Policy in the Office of the Premier of Ontario, where he oversaw work related to innovation policy and economic growth, education and workforce development, and government services modernization. He previously worked on Canada’s National AI Strategy at the Canadian Institute for Advanced Research (CIFAR). He holds a Masters of Global Affairs from the University of Toronto.

Tamara Seales, President at Seaford Pharmaceuticals, is recognized as a dynamic and visionary leader responsible for guiding the company’s administration, finance, strategy, and marketing. 

Tamara supports Seaford Pharmaceuticals’ charitable initiatives, including the establishment of a pediatric clinic in Jamaica and substantial contributions to disaster relief efforts. She is also actively engaged in fundraising activities dedicated to women’s health, cancer research, and brain health causes.

Her inspirational leadership, coupled with her unwavering commitment to philanthropy and industry advancement, guides Seaford Pharmaceuticals and the pharmaceutical landscape toward a brighter, more equitable, and healthier future. Tamara has an MBA from the Schulich School of Business, also at York University.